Clinical Trial Update: Microbiota Study in Liver Transplanted Patients

View source ↗

Summary

A microbiota-focused clinical trial in patients with cirrhosis and hepatocellular carcinoma undergoing liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Cirrhosis, Hepatocellular Carcinoma | Status: COMPLETED